The probiotics market is evolving faster than ever. Consumers no longer settle for “general gut health” – they’re demanding precision, proof, and purpose. At Kaneka Probiotics, we help brands deliver on that demand by transforming advanced probiotic science into targeted, clinically validated solutions that inspire trust, create differentiation, and improve lives across the U.S. and Canada.
From Research to Real-World Impact
Our journey began with a vision: to harness the microbiome’s untapped potential and turn it into measurable health benefits for consumers everywhere. That vision led us to invest early in research, clinical validation, and strain discovery – setting a new standard for probiotic innovation.
- In 2005, we established a private 500+ strain bank from samples of non-industrialized, healthy populations, building a foundation of microbial diversity for future innovation
- By 2011, our first clinical trials were underway, underscoring our commitment to evidence-based science.
- Just two years later, in 2013, we launched our first probiotics to market.
- In 2022, Kaneka Corporation acquired AB-BIOTICS, significantly expanding our expertise in microbiome research and development.
Today, our pipeline spans probiotics, postbiotics, and next-generation biotics that go far beyond digestion. Our solutions support immune resilience, women’s health, cardiometabolic function, cognition, mood and stress, gastrointestinal health, skin health, weight management, infant health, oral/gum health, and healthy aging – helping brands respond to the most urgent wellness needs of today’s consumers.
Why Precision Matters
In probiotics, more CFUs don’t mean better results. True impact comes from precision: selecting strains with proven mechanisms of action and clinical validation for specific health outcomes. This strain-specific approach ensures measurable results in areas like immune function, cognition, and women’s wellness.
For brands, this means stronger product differentiation in saturated categories, greater consumer trust through results – not just numbers – and the ability to deliver meaningful solutions that align with evolving health needs.
A Partner for Innovation
Kaneka Probiotics isn’t just a manufacturer or supplier. We’re a true partner in helping brands succeed. Whether you’re looking for:
- Turnkey, ready-to-market formulations,
- Custom private label solutions, or
- Support with regulatory compliance, manufacturing expertise – we provide the tools, knowledge, and resources to bring your ideas to life.
Your Future with Kaneka Probiotics
Our mission is simple: to propel the biotics sector forward – advancing innovation, and inspiring new solutions that deliver measurable impact for consumers.
Looking to the future, science will remain at the forefront as we expand our clinical research and introduce patented innovations like our award-winning KABP® Menopause, KABP® Baby Colic and KABP® Metabalance solutions. We’ll continue to grow our FDA GRAS-recognized portfolio, alongside category-leading offerings in cognitive health, immune resilience, healthy aging and women’s wellness.
For our partners, this means more than just access to ingredients – it means actionable insights, evidence-based innovation, and tailored solutions to help launch differentiated, high-impact products that succeed in competitive markets.